Special Call to Action for Rep Schakowsky Constituents (IL-9)
Your Representative, Jan Schakowsky, is the House sponsor of the Lymphedema Treatment Act, so we have something important to ask of you. The next big package that Congress takes up
Your Representative, Jan Schakowsky, is the House sponsor of the Lymphedema Treatment Act, so we have something important to ask of you. The next big package that Congress takes up
House members are already home in their districts, and Senate members will soon be headed home for the August recess as well. Now is a great time to try and
297 Representatives and Senators are now supporting the Lymphedema Treatment Act, which is 56% of Congress! Congress will soon begin their long August recess, and not return to session until after
We now have a majority of the House supporting the Lymphedema Treatment Act, and are just two Senators away from having a super majority (two-thirds) level of support in the
Our organization recently hired Avalere, a healthcare analytics firm that is a well-known and respected name on Capitol Hill. We asked them to estimate the potential savings that would result
As of today, 213 of the 435 members of the House of Representatives have cosponsored the Lymphedema Treatment Act! Check the list below to see if your Representative is already
Please take a moment to contact any Senators not yet cosponsoring the LTA by emailing their offices, and also using the information below to leave a phone message. Congress is
This Saturday, July 10th, is Chronic Disease Day. You can help us spread awareness about Lymphedema and the Lymphedema Treatment Act by submitting a letter to the editor. Just fill
Until it is possible to resume our annual in-person Lymphedema Lobby Days on Capitol Hill we will be organizing virtual Zoom meetings with Congressional offices. Additionally, for the present time,
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

